NCT00000728View on ClinicalTrials.gov

Phase I Trial of the Combination of Zidovudine and Recombinant Interleukin-2 in Patients With Persistent Generalized Lymphadenopathy

PHASE1CompletedINTERVENTIONAL

Enrollment

20

Participants

Timeline

Start Date

Not specified

Study Completion Date

April 30, 1990

Conditions

HIV Infections

Interventions

DRUG

Zidovudine

DRUG

Aldesleukin

Trial Locations (1)

94305

Stanford Univ School of Medicine, Stanford

All Listed Sponsors

lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH